The Medidata Partner Program continues to expand its relationships throughout the life sciences industry with the addition of a number of contract research organizations (CRO) to the program during 2021.
As the industry's largest global community of contract research organizations which has more than 200 partners and includes nine of the ten largest CROs, the Medidata Partner Program provides a unique ecosystem of carefully selected partners who provide clinical trial support built upon the industry's leading end-to-end data and analytics platform, the Medidata Clinical Cloud.
In 2021, Medidata welcomed new partners, including Amencefs, ClinFocus LLC, CRC Oncology, eStart Medical Technology Co., Ltd., Health Data Specialists (HeaDS), and The Emmes Company LLC.
“Our Partners are innovators, disruptors, and industry leaders,” said Joan Shaiman, senior vice president, Partners at Medidata. ‘Together, we help sponsors fully leverage the unique value of the Medidata platform to accelerate study startup, improve overall operational performance of clinical trials, and outsource trials more intelligently."
The Medidata Partner Program enables CROs to respond quickly to sponsors’ requirements by providing a wide array of offerings, including industry-recognized accreditations, sales support including bid defense and RFPs, as well as opportunities to influence the innovation of our clinical trials solutions through product team engagement. This allows our Partners to successfully service and address the needs of their Sponsors, Sites and Patients.
One of Medidata’s new Partners is Amencefs, which provides Data Management and EDC programming services to small and mid-size pharmaceutical and biotechnology companies for phase I through IV clinical trials with a therapeutic focus on hypertension devices, central nervous system and oncology.
“Through our own experiences in clinical research we have come to know that Medidata is recognized in the industry for building trusted long-term partnerships with clinical research organizations,” said Agbessi Gblokpor, Director of Programming and Business Operations at Amencefs. “It was important for us to join the Medidata Partner Program as the studies we are able to win and deliver on are made possible by the Medidata products that we use.”
Sponsors looking to leverage Medidata technologies in their clinical trials can visit our partner profile page and search for qualified CROs based upon partner type, therapy or therapeutic area of expertise, geography, and technology.
For more information, contact: Tom Paolella / tpaolella@mdsol.com.